New drug could keep aggressive uterine cancer at bay
NCT ID NCT06712472
First seen Jan 21, 2026 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This study tests whether taking a daily pill called olaparib for one year after standard treatment can help prevent endometrial cancer from coming back. About 554 women with a specific genetic type of endometrial cancer (p53abn) will either receive olaparib or be observed. The goal is to see if the drug improves the time without cancer returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU De LIMOGES
RECRUITINGLimoges, 87000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Antoine LACASSAGNE
RECRUITINGNice, 06189, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier D'Albi
RECRUITINGAlbi, 81000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier de Carcassonne
RECRUITINGCarcassonne, 11000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre LEON BERARD
RECRUITINGLyon, 69008, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Besancon
RECRUITINGBesançon, 25030, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu Dijon
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Sainte Anne
RECRUITINGStrasbourg, 67000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupe Hospitalier Mutualiste de Grenoble
NOT_YET_RECRUITINGGrenoble, 38000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hopital Cochin
NOT_YET_RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INSTITUT CANCEROLOGIE DE L'OUEST-St HERBLAIN
RECRUITINGSaint-Herblain, 44800, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Cancerologie de L'Ouest-Angers
RECRUITINGAngers, 49055, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Marie-Curie
RECRUITINGParis, 75005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13009, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.